AXIM - AXIM Biotechnologies, Inc.
| Previous Close | 1.9100 |
| Open | 1.9500 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 1.9000 - 1.9900 |
| 52 Week Range | 0.4600 - 6.9600 |
| Volume | 111,043 |
| Avg. Volume | 150,150 |
| Market Cap | 116.59M |
| Beta (3Y Monthly) | -5.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 |
| Earnings Date | May 1, 2018 - May 7, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Market Exclusive•2 days ago
Medical Marijuana, Inc. Affiliate Kannaway In CBD Gum Partnership With AXIM
Medical Marijuana, Inc. (OTCMKTS:MJNA) has announced that subsidiary Kannaway® has placed a substantial purchase order from AXIM Biotechnologies (OTCMKTS:AXIM) for its CBD nutraceutical chewing gum. Kannaway® creating a nutraceutical brand Kannaway is a lifestyle network offering CBD hemp products. Blake Schroeder, the Chief Executive Officer, said that the subsidiary was proud to work together with […]The post Medical Marijuana, Inc. Affiliate Kannaway In CBD Gum Partnership With AXIM appeared first on Market Exclusive.
- PR Newswire•2 days ago
Medical Marijuana, Inc. Subsidiary Kannaway® Places Significant Initial Purchase Order for Major Investment Company AXIM® Biotechnologies CBD Chewing Gum
SAN DIEGO , Feb. 14, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States , announced that its subsidiary Kannaway® , the first ...
- GlobeNewswire•4 days ago
AXIM® Biotechnologies Announces Significant Initial Purchase Order for Nutraceutical Product With Leading Direct Selling Company
AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or “AXIM”) (AXIM), a world leader in cannabinoid research and development, today announced that the company has received a significant initial purchase order (“PO”) from Kannaway®, the first hemp lifestyle network to offer cannabidiol (“CBD”) hemp botanical products, for its nutraceutical chewing gum product.
- Benzinga•13 days ago
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
The World Health Organization recommended the re-scheduling of cannabis and some of its main components, recognizing the plant’s medical potential and acknowledging the need for further research around it, only days after the Israel approved a plan to export cannabis. On the markets front, Slang Worldwide Inc (CNSX: SLNG) started trading in Canada. “The successful SLANG Worldwide IPO is just what the cannabis community needed,” Debra Borchardt, CEO of Green Market Report, told Benzinga.
- GlobeNewswire•18 days ago
New U.S. Patent Issuance Granted to AXIM® Biotechnologies for Oral Care Composition Containing Cannabinoids
NEW YORK, Jan. 29, 2019 -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that.
- GlobeNewswire•last month
AXIM® Biotechnologies Launches New Website and Management Presentation To Outline Strategic Business Initiatives
AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or “AXIM”) (AXIM), a world leader in cannabinoid research and development, today announced the launch of a new corporate website and release of its most recent management presentation, which outlines the Company’s strategic initiatives including the prioritization of its clinical development program by probability of success and fiscal considerations. “One of my first enterprises as CEO of the company was to implement a strategic business plan for the short and midterm that focused our clinical development research on programs with the best chance of success with lesser fiscal obligations,” said AXIM® Biotech CEO, John W. Huemoeller II. “We felt that a redesign of our website and management presentation was an important step in making AXIM’s direction clear and making that information available to our valued shareholders.
- GlobeNewswire•last month
AXIM® Biotechnologies Appoints New Chief Executive Officer
NEW YORK, Jan. 08, 2019 -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the.
- Motley Fool•4 months ago
The Only 2 Marijuana Stocks to Fall in September
Though nearly every pot stock rose in September, these two weed stocks were outliers.
- Motley Fool•10 months ago
3 Things to Love and Hate About Medical Marijuana, Inc.'s Full-Year Report
It's another mixed bag for the first publicly traded pot stock in the U.S.
- Motley Fool•10 months ago
3 Marijuana Stocks You Couldn't Pay Me to Buy
These pot stocks are bad news for investors.
- Motley Fool•11 months ago
This Pot Stock Is Trading Below Its Book Value
Despite being an apparent book value bargain, this marijuana stock comes with big risks.
- Zacks Small Cap Research•11 months ago
AXIM Biotechnologies (AXIM) Advancing Multi-faceted Medical CBD and THC Pipeline
OTC:AXIM Summary • AXIM Biotechnologies (OTC:AXIM) holds the intellectual property rights to the controlled-release, trans-mucosal (chewing gum) drug delivery platform for medical cannabinoids. o The company ...
